誉衡药业：10月13日召开董事会会议

Group 1 - The core point of the article is that Yuheng Pharmaceutical (SZ 002437) held its seventh fifth board meeting on October 13, 2025, via telecommunication, where it reviewed the proposal to amend the "External Guarantee Management System" [1] - For the first half of 2025, Yuheng Pharmaceutical's revenue composition was as follows: chemical drugs accounted for 90.39%, traditional Chinese medicine for 9.38%, and other businesses for 0.22% [1] - As of the time of reporting, Yuheng Pharmaceutical had a market capitalization of 7.1 billion yuan [1]